The global point-of-care ultrasound (PoCUS) devices market had a valuation of $2,096.6 million in 2019 and it is predicted to advance at a CAGR of 7.4% between 2020 and 2030. According to the estimates of the market research firm, P&S Intelligence, the market will generate a revenue of $4,494.4 million by 2030. The surging healthcare expenditure in various countries, the soaring geriatric population, and the rising incidence of chronic diseases are the main factors driving the advancement of the market.

Request to Get the Sample Pages at:https://www.psmarketresearch.com/market-analysis/eu-pocus-device-ma...

With the rapid rise in the population of geriatric people, the sales of medical devices such as point-of-care ultrasound devices that assist in the management and diagnosis of diseases are climbing all over the world. PoCUS devices enable the proper point-of-care diagnosis, management, and treatment of various chronic diseases. For instance, the usage of these devices allows primary care healthcare practitioners to non-invasively diagnose urinary incontinence in geriatric people and screen them for prostatic enlargement and abdominal aortic aneurysm (AAA).

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=eu-pocus-...

Ultrasound allows real-time imaging and is therefore, highly useful in image-guided minimally invasive surgical procedures. Additionally, portable ultrasound devices have small sizes and low weights, exhibit excellent performance, and have a good battery life. Because of these traits, the sales of portable ultrasound devices are surging all over the world. Based on type, the point-of-care ultrasound devices market is categorized into therapeutic and diagnostic. Of these, the therapeutic category is predicted to demonstrate faster growth in the coming years.

On the other hand, the largest market expansion will be witnessed in Europe in the future years. This will be because of the growing incidence of chronic diseases, the soaring healthcare expenditure, and the rapid advancements being made in point-of-care ultrasound technology. As per the International Diabetes Federation (IDF), in Europe, 68 million people in the age bracket- 20–79 years is predicted to be diagnosed with diabetes by 2045.

Hence, it is safe to say that the market will exhibit huge expansion across the world in the upcoming years, primarily because of the rising incidence of chronic diseases, the surging geriatric population, and the burgeoning requirement for point-of-care disease diagnosis and treatment.